Bristol-Myers Diabetes Drug Helps Obese Adolescents Lose Weight

Bristol-Myers Squibb Co.’s diabetes drug exenatide helped severely obese teenagers lose weight, according to a study that suggests a new use for some medicines used to control blood sugar.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.